<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=An_Non-visual_Gemstone_Of_Dabrafenib</id>
		<title>An Non-visual Gemstone Of Dabrafenib - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=An_Non-visual_Gemstone_Of_Dabrafenib"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=An_Non-visual_Gemstone_Of_Dabrafenib&amp;action=history"/>
		<updated>2026-05-05T12:40:30Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=An_Non-visual_Gemstone_Of_Dabrafenib&amp;diff=131460&amp;oldid=prev</id>
		<title>Curleregypt6: Створена сторінка: Hematopoietic cytokines were measured with the enzyme-linked immunosorbent [http://en.wikipedia.org/wiki/Ritonavir Ritonavir] assay (ELISA) (SCF, GM-CSF, G-CSF,...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=An_Non-visual_Gemstone_Of_Dabrafenib&amp;diff=131460&amp;oldid=prev"/>
				<updated>2017-01-16T16:13:32Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Hematopoietic cytokines were measured with the enzyme-linked immunosorbent [http://en.wikipedia.org/wiki/Ritonavir Ritonavir] assay (ELISA) (SCF, GM-CSF, G-CSF,...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Hematopoietic cytokines were measured with the enzyme-linked immunosorbent [http://en.wikipedia.org/wiki/Ritonavir Ritonavir] assay (ELISA) (SCF, GM-CSF, G-CSF, M-CSF�CQuantikine Human HGFs Immunoassay, R&amp;amp;D systems; IL-3 �C Human ELISA kit, Invitrogen Corporation), according to the manufacturer's protocols. The intra-assay coefficient of variation (CV%) of IL-3 is reported to be 5.3% at a mean concentration of 87.2 pg/ml, standard deviation�CSD = 4.6, SCF �C to be 2.0% at a mean concentration of 655 pg/ml, SD=12.9, of GM-CSF �C to be 9.5% at a mean concentration of 3.68 pg/ml, SD=0.35, of G-CSF �C to be 6.8% at a mean concentration of 60 pg/ml, SD=4.1, of M-CSF �C to be 3.4% at a mean concentration of 227 pg/ml, SD=7.7. The inter-assay coefficient of variation (CV%) of IL-3 to be 6.9% at a mean concentration of 85.3 pg/ml, SD = 5.9, SCF �C to be 5.1% at a mean concentration of 703 pg/ml, SD=36.0, of GM-CSF �C to be 23.5% at a mean concentration of 2.8 pg/ml, SD=0.66, of G-CSF �C to be 8.3% at a mean concentration of 62.6 pg/ml, SD=5.2, of M-CSF �C to be 3.1% at a mean concentration of 232 pg/ml, SD=7.3. The assay showed no significant cross-reactivity or interference with a variety of other human cytokines and other growth factors. Plasma concentrations of CA 15-3 were measured by chemiluminescent microparticle immunoassay (CMIA) (Abbott, Chicago, IL, USA). [http://www.selleckchem.com/products/sch772984.html SCH772984 cell line] The intra-assay CV for CA 15-3 is reported to be 2.2% at a mean concentration of 27.0 U/ml, SD=0.6. The inter-assay CV for CA 15-3 is reported to be 2.6% at a mean concentration of 27.0 U/ml, SD=0.7. The statistical analysis was performed using the [http://www.selleckchem.com/products/dabrafenib-gsk2118436.html selleck chemicals] STATISTICA 8.0 PL program. A preliminary statistical analysis (Chi-square test) revealed that the distribution of cytokine and tumor marker levels did not follow normal distribution. Consequently, the Mann-Whitney U-test was used for the statistical analyses between cancer and control groups. Additionally, statistical analyses between the groups with different BC stages were performed using the Kruskal-Wallis test, and a multivariate analysis of various data with the use of the post-hoc Dwass-Steele-Crichlow-Flinger test. Data were presented as median and range. The Spearman rank correlation was used in the correlation analyses. Statistically significant differences were defined as comparisons resulting in p&lt;/div&gt;</summary>
		<author><name>Curleregypt6</name></author>	</entry>

	</feed>